Status:
UNKNOWN
Efficacy of 18-Months of Antidepressive Medication Plus CBT or Dynamic or Supportive Psychotherapy for Recurrent Major Depression
Lead Sponsor:
Sir Mortimer B. Davis - Jewish General Hospital
Conditions:
Major Depression
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
Major Depressive Disorder affects approximately 16% of the adult population over the lifetime. Controlled studies indicate that short-term antidepressive medications or psychotherapy produce full remi...
Detailed Description
Major Depressive Disorder affects approximately 15% of the adult population over a lifetime. Controlled studies indicate that short-term antidepressive medications or psychotherapy produce full remiss...
Eligibility Criteria
Inclusion
- DSM-IV major depressive episode with at least one prior MDE episode, and
- HRSD-17 score above 16 at screening and intake (one-week apart)
Exclusion
- bipolar type I disorder
- any psychotic disorder
- serious alcohol or substance abuse disorder
- organic mental disorder
- serious suicidal intent that warrants imminent hospitalization
- first trimester pregnancy
- likelihood of moving too far away to continue treatment for 18-months
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00220623
Start Date
August 1 2004
Last Update
September 22 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Community and Family Psychiatry
Montreal, Quebec, Canada, H3T 1E4